| scholarly article | Q13442814 |
| P2093 | author name string | Jing Li | |
| Mo Xian | |||
| Xu Shi | |||
| Xiaohui Zeng | |||
| Mulin Feng | |||
| Rundong Qin | |||
| Qiujuan Su | |||
| P2860 | cites work | Coupling antibody to cyanogen bromide-activated sepharose | Q41789938 |
| Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. | Q44574133 | ||
| [The usefulness of CD203c expression measurement on basophils after activation with grass pollen and Dermatophagoides pteronyssinus antigens. Preliminary study]. | Q45996775 | ||
| Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity | Q46675736 | ||
| A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients | Q47656716 | ||
| Modified antigenic reactivity of anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: conversion with immunotherapy and relation to subclass expression | Q47784325 | ||
| Wasp venom immunotherapy changes IgG antibody specificity | Q47788110 | ||
| House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial | Q47940422 | ||
| A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China. | Q51128478 | ||
| Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. | Q51644402 | ||
| Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios. | Q51727137 | ||
| CD-sens: a biological measure of immunological changes stimulated by ASIT. | Q51819148 | ||
| Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy. | Q53197600 | ||
| A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. | Q53243033 | ||
| Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity | Q57267001 | ||
| Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy | Q58617547 | ||
| Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children | Q34185603 | ||
| SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma | Q34577305 | ||
| World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) | Q34589248 | ||
| Immunoglobulin G4: an odd antibody | Q34604625 | ||
| Allergenicity of Euroglyphus maynei and its cross-reactivity with Dermatophagoides species | Q34731182 | ||
| IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens | Q35566586 | ||
| Mechanisms of immunotherapy. | Q35811876 | ||
| Peripheral basophil reactivity, CD203c expression by Cryj1 stimulation, is useful for diagnosing seasonal allergic rhinitis by Japanese cedar pollen | Q36082339 | ||
| IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy | Q36545702 | ||
| Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. | Q36734980 | ||
| GINA guidelines on asthma and beyond | Q36734993 | ||
| Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? | Q38194290 | ||
| Specific immunoglobulin E and immunoglobulin G4 toward major allergens of house-dust mite during allergen-specific immunotherapy | Q39155862 | ||
| A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever | Q40862244 | ||
| Is Immunotherapy-Induced Birch-Pollen-Specific IgG4 a Marker for Decreased Allergen-Specific Sensitivity? | Q64134943 | ||
| Isotype-associated recognition of allergen epitopes and its modulation by antigen dose | Q71693267 | ||
| Releasability of human basophils: Cellular sensitivity and maximal histamine release are independent variables | Q72070626 | ||
| Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome | Q77321971 | ||
| Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy | Q77924919 | ||
| The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy | Q80541128 | ||
| Analysis of basophil activation by flow cytometry in pediatric house dust mite allergy | Q80678369 | ||
| Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy | Q82473859 | ||
| Allergen immunotherapy | Q82998312 | ||
| SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial | Q83346456 | ||
| Serum immunologic markers for monitoring allergen-specific immunotherapy | Q84003287 | ||
| Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber | Q84333316 | ||
| Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy | Q84365456 | ||
| Specific IgG4 production during house dust mite immunotherapy among age, gender and allergic disease populations | Q84935049 | ||
| Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response? | Q85212791 | ||
| Basophil activation test in the diagnosis and monitoring of mastocytosis patients with wasp venom allergy on immunotherapy | Q87194561 | ||
| Functional and Immunoreactive Levels of IgG4 Correlate with Clinical Responses during the Maintenance Phase of House Dust Mite Immunotherapy | Q88573983 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | immunotherapy | Q1427096 |
| Dermatophagoides pteronyssinus | Q4573411 | ||
| P304 | page(s) | 30 | |
| P577 | publication date | 2020-02-20 | |
| P1433 | published in | Frontiers in Cell and Developmental Biology | Q27725488 |
| P1476 | title | Allergen Immunotherapy-Induced Immunoglobulin G4 Reduces Basophil Activation in House Dust Mite-Allergic Asthma Patients | |
| P478 | volume | 8 |
Search more.